Skip to main content

Table 2 Overall survival multivariate analysis

From: Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study

  Categories N HR 95%CI P value
Visceral metastases No 8 1   0.01
Yes 52 6.57 [1.17; 36.97]
Metastases molecular subtype Luminal A 8 1   < 0.001
HER2 15 1.29 [0.32; 5.18]
Triple negative 13 10.47 [2.73; 40.17]
Luminal B 24 3.49 [1; 12.19]
Number of metastatic sites 1–2 37 1   0.002
3+ 23 2.9 [1.5; 5.62]
LAMA2 mutation in metastasis Wild type 58 1   0.043
mutated 2 8.67 [1.43; 52.4]